Biond is a pharmaceutical company that researches and develops immuno-therapies for oncology and autoimmune diseases. Read more

1 Followers on Owler
1 Followers on Owler
1 Followers on Owler
1 Followers on Owler

Biond is a pharmaceutical company that researches and develops immuno-therapies for oncology and autoimmune diseases. Read more

Tehila Ben Moshe's photo - Co-Founder & CEO of Biond Biologics

Co-Founder & CEO

Tehila Ben Moshe

CEO Approval Rating

84/100

Founded:

2016

Status:

PrivateIndependent Company

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Genelux is the biggest rival of Biond Biologics. Genelux is headquartered in San Diego, California, and was founded in 2001. Like Biond Biologics, Genelux also operates in the Biotechnology space. Genelux generates 234% the revenue of Biond Biologics.

Virometix is Biond Biologics's #2 competitor. Virometix is a Private company that was founded in Schlieren, Zurich in 2009. Like Biond Biologics, Virometix also works within the Biotechnology sector. Virometix has 22 more employees vs. Biond Biologics.

Turnstone Biologics has been one of Biond Biologics's top competitors. Turnstone Biologics's headquarters is in Ottawa, Ontario, and was founded in 2015. Turnstone Biologics operates in the Biotechnology industry. Turnstone Biologics generates 171% of Biond Biologics's revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 18 a good estimate for Biond Biologics's Employee count?

Acquisitions

No recent acquisitions found related to Biond Biologics

Biond Biologics Funding History

$17M

Since Biond Biologics was founded in 2016, it has participated in 1 round of funding. In total Biond Biologics has raised $17.0M. Biond Biologics' funding round was on Jan 2019 for a total of $17.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series B
Jan 2019
$17M

Israel Biotech Fund

Since Biond Biologics was founded in 2016, it has participated in 1 round of funding. In total Biond Biologics has raised $17.0M. Biond Biologics' funding round was on Jan 2019 for a total of $17.0M

Investments

No recent investments found related to Biond Biologics

Biond Biologics News

Biond Biologics Press Releases

Social Media

Headquarters

- Misgav Industrial Park

Nahariyya, North District22101

972-4-8844337

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Biond is a pharmaceutical company that researches and develops immuno-therapies for oncology and autoimmune diseases. Biond Biologics was founded in 2016. Biond Biologics' headquarters is located in Nahariyya, North District, IL 22101. It has raised 1...

CEO

Biond Biologics's Co-Founder & CEO, Tehila Ben Moshe, currently has an approval rating of 84%. Biond Biologics's primary competitors are Genelux, Virometix & Turnstone Biologics.

Website

biondbio.com

Frequently Asked Questions about Biond Biologics

  1. When was Biond Biologics founded?

    Biond Biologics was founded in 2016
  2. Who is Biond Biologics's CEO?

    Biond Biologics's CEO is Tehila Ben Moshe
  3. How much revenue does Biond Biologics generate?

    Biond Biologics generates $3.5M in revenue
  4. How much funding does Biond Biologics have?

    Biond Biologics has historically raised $17M in funding
  1. Where is Biond Biologics's headquarters?

    Biond Biologics's headquarters is in Nahariyya North District, IL
  2. How many employees does Biond Biologics have?

    Biond Biologics has 18 employees
  3. What sector does Biond Biologics operate in?

    Biond Biologics is in Biotechnology, Pharmaceuticals
  4. Who are Biond Biologics's competitors?

    Biond Biologics's top competitors are Genelux, Virometix, Turnstone Biologics